Hepatitis C treatment cures over 90% of patients with cirrhosis 12 wks of an investigational oral therapy cured hepatitis C infection in > 90% of patients with liver cirrhosis and was well tolerated by these patients, according to a new study. Hepatitis C virus is the No. 1 driver of cirrhosis, liver transplants and liver cancer in the United States NOTE: normally hep C cure rates in patients with cirrhosis (liver scarring) have been lower than 50% and treatment was not safe for many of these patients. >> The new regimen is interferon-free and consists of several agents -- ABT-450/ritonavir, ombitasvir, dasabuvir and ribavirin. Post-last dose, no hepatitis C virus was detected in the bloodstream of 91.8% of patients who took the pills for 12 wks. Among patients treated for 24 wks, 95.9% were virus-free 12 wks after the end of therapy.
Posted on: Sun, 13 Apr 2014 16:41:45 +0000
Trending Topics
Recently Viewed Topics
© 2015